Keep up to speed with the latest advances in Controlled-Release

PRLog (Press Release) - Jan. 20, 2012 - Examining the latest developments in nanomedicine, join SMi’s ninth annual Controlled-Release conference, featuring fresh presentations from leading companies in this interesting field.  Topics include enhancing in vivo circulation time, extending dissolution kinetics, and improving delivery with drug-porous nanocarriers, lipid-based compounds and biologics.  Whether your interests lie in formulation, particle design or drug delivery book now to secure your place!  

6 Key reasons why you should attend this interesting event include:

•    Increasing patent revenue for oral and non oral drug delivery products
•    Extending product lifecycles through reformulation to keep market share
•    Accelerating to phase III faster with lipid-based compounds
•    Improving manufacturing efficiency and scale-ability for miniaturisation and bead milling
•    Reducing costs with in silico applications to maximise commercial development
•    Implementing lessons for ADMET testing when using nanoparticles

There will also be two interactive pre-conference workshops held on the 27th March 2012 on.....

A.   Accelerating first-in-human studies (FIH) with lipid-based formulations
Hosted by: David J. Hauss, Principal, Hauss Associates
Hassan Benameur, Senior Director Pharmaceutical Sciences, Capsugel
Senior Representative, Gattefossé
8.30am-12.30pm

B.    A trip through the life and work of a patent
Hosted by: Jonathan Couchman, Partner, Harrison Goddard Foote (HGF) and Martyn Fish, Partner, HGF Law
1.30pm-5.30pm

For more information and to book your place visit http://www.smi-online.co.uk/controlledrelease38.asp

Alternatively, contact Ninica Hussain at Tel: +44 (0)20 7827 6115 or Email: nhussain@smi-online.co.uk